From: Prenatal epigenetics diets play protective roles against environmental pollution
Pollution | Exposure stage | Epigenetic change | Ref. |
---|---|---|---|
Particulate matter | Prenatal | Altered DNA methylation at CpG sites | [65] |
First trimester | Positive correlation with placental global DNA methylation | [74] | |
Second trimester | Lower placental leptin promoter methylation | [78] | |
Early pregnancy | Associated with placental DNA methylation of LINE1 and HSD11B2 | [75] | |
Prenatal | Decreased expression of miR-21, miR-146a and miR-222; increased expression of miR-20a and miR-21 | [80] | |
Gestation | Increased mtDNA methylation levels and decreased LINE-1 methylation levels | [77] | |
Prenatal | Decrease in global DNA methylation for whole pregnancy | [73] | |
Prenatal | Increased DNA methylation in LINE1, OGG1, APEX and PARP1 | [79] | |
Smoking | Prenatal | Nearly 3000 CpGs corresponding to genes differentially methylated in offspring | [85] |
Maternal | Altered DNA methylation levels at CpG sites of GFI1, AHRR and PRNP gene in male and female, differentially | [110] | |
In utero | Impact key biological pathways through epigenetic modification | [84] | |
Maternal | Differential methylation of MYO1G, CNTNAP2 and FRMD4A genes in children blood | [107] | |
In utero | Global DNA hypomethylation; 31 CpG sites associated to 25 genes | [99] | |
Prenatal | Altered methylation at 15 CpG sites | [100] | |
Prenatal | Differential methylation at five CpGs in MYO1G and CNTNAP2; persist in exposed offspring for many years | [88] | |
In utero | Increased CpG methylation in FRMD4A and Cllorf52; reproducible epigenetic changes persist into childhood | [87] | |
In utero | Altered methylation at 185 CpGs of 110 gene regions in infants | [101] | |
In utero | Hypomethylation of AHRR in the cord blood mononuclear cells, buccal epithelium and placenta tissue | [44] | |
In utero | Altered methylation at TSLP promoter | [106] | |
Maternal | Altered methylation patterns of a few loci within the RUNX3 gene | [102] | |
In utero | Increased IGF2 DMR | [105] | |
In utero | Altered LINE-1 and AluYb8 methylation levels | [83] | |
Maternal | Differential DNA methylation at epigenome-wide for 26 CpGs mapped to 10 genes | [104] | |
Maternal | Differential epigenome-wide placental DNA methylation | [82] | |
Gestation | Decreased methylation of Sat2 | [96] | |
Maternal | Increased DNA methylation in the BNDF-6 exon | [108] | |
Gestation | Downregulation of miR-16, miR-21 and miR-146a in placenta | [109] | |
In utero | Global DNA methylation inversely correlates with cotinine levels in cord blood | [95] | |
In utero | Decreased methylation at CYPIAI promoter in the placenta | [103] | |
Prenatal | Lower methylation of AluYb8; differential methylation of LINE1; increased methylation of AXL and PTPRO | [98] | |
Polycyclic aromatic hydrocarbons | Prenatal | Inverse relationship with LINE1 DNA methylation in cord blood | [119] |
Prenatal | Decreased global methylation in umbilical cord white blood cells | [118] | |
Prenatal | Altered methylation in 5′-CpG islands of ACSL3 | [120] | |
NO2 | Prenatal | Related alteration of ADORA2B methylation | [65] |
Prenatal | Differential offspring DNA methylation in antioxidant and mitochondria-related genes | [122] |